Drug Shortage Report for CYTOVENE
| Report ID | 184528 |
| Drug Identification Number | 02162695 |
| Brand name | CYTOVENE |
| Common or Proper name | ganciclovir for injection |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | GANCICLOVIR |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mg/vial |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-14 |
| Estimated end date | 2023-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-05-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2023-05-29 | French | Compare |
| v8 | 2023-05-29 | English | Compare |
| v7 | 2023-05-02 | French | Compare |
| v6 | 2023-05-02 | English | Compare |
| v5 | 2023-03-31 | French | Compare |
| v4 | 2023-03-31 | English | Compare |
| v3 | 2023-02-15 | English | Compare |
| v2 | 2023-02-14 | French | Compare |
| v1 | 2023-02-14 | English | Compare |
Showing 1 to 9 of 9